[144] Nexxen International Ltd. SEC Filing

Rhea-AI Filing Summary

Nexxen International Ltd. (NEXN) filed a Form 144 disclosing a proposed sale of 52,266 ordinary shares through Oppenheimer & Co. Inc. on or about 08/15/2025, with an aggregate market value of $487,641.78. The filing shows the securities were acquired as Restricted Stock Units on 06/22/2021 (91,463 shares) and 11/18/2024 (13,067 shares). The total number of shares outstanding is reported as 65,562,670, so the proposed sale equals approximately 0.08% of shares outstanding. The filer reported no sales of the issuer's securities in the past three months and provided the standard signature representation regarding possession of material nonpublic information.

Positive

• Full Rule 144 disclosure provided with broker, share count, value, and acquisition details
• Sale size is small — approximately 0.08% of shares outstanding, indicating limited market impact
• Securities originated as RSUs, showing the shares were granted by the issuer rather than acquired externally

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider disclosed a small, routine sale of vested RSUs totaling 52,266 shares worth ~$487.6k; impact to equity is immaterial.

The filing documents a planned brokered sale under Rule 144 of ordinary shares that were granted as Restricted Stock Units in 2021 and 2024. The aggregate value and share count are explicitly stated and the sale represents roughly 0.08% of outstanding shares, indicating a de minimis dilution or market impact. No other recent insider sales were reported. From a trading-impact perspective this is a routine compliance filing rather than a material corporate event.

Corporate Governance Expert

TL;DR: Form 144 is a standard disclosure of an insider sale; it affirms compliance but conveys no material governance change.

The notice shows the seller relied on Rule 144 procedures and used a registered broker to execute the transaction. Acquisition details identify the shares as RSUs awarded by the issuer, which is typical for employee or executive compensation. The declaration that there are no undisclosed material adverse facts is standard. There is no indication of irregular governance actions or multiple rapid insider dispositions in the filing.

08/15/2025 - 06:17 AM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	52266	487641.78	65562670	08/15/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	06/22/2021	Restricted Stock Units	Issuer			91463	06/22/2021	N/A
Ordinary	11/18/2024	Restricted Stock Units	Issuer			13067	11/18/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Nexxen (NEXN) disclose in the Form 144?

The filer disclosed a proposed sale of 52,266 ordinary shares through Oppenheimer & Co. Inc. on or about 08/15/2025, valued at $487,641.78.

How many shares outstanding does NEXN report and what percentage is the proposed sale?

The filing reports 65,562,670 shares outstanding; the proposed sale of 52,266 shares equals about 0.08% of outstanding shares.

How were the shares being sold acquired?

The shares were acquired as Restricted Stock Units (RSUs) on 06/22/2021 (91,463 shares) and 11/18/2024 (13,067 shares).

Did the filer report any other sales of issuer securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Which broker is listed to execute the sale?

The sale is to be executed by Oppenheimer & Co. Inc., 85 Broad St., New York, NY 10004.